CFRA upgraded Novavax (NASDAQ: NVAX) from Hold to Buy with a price target of $71.00 (from $57.00).

For an analyst ratings summary and ratings history on Novavax click here. For more ratings news on Novavax click here.

Shares of Novavax closed at $47.54 yesterday.